Orion Portfolio Solutions’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.06M Buy
63,706
+19,122
+43% +$710K 0.02% 689
2024
Q4
$1.36M Buy
44,584
+3,963
+10% +$127K 0.01% 889
2024
Q3
$1.14M Sell
40,621
-40,829
-50% -$1.01M 0.01% 985
2024
Q2
$1.85M Buy
81,450
+13,329
+20% +$308K 0.02% 675
2024
Q1
$2.07M Buy
68,121
+14,360
+27% +$481K 0.02% 646
2023
Q4
$1.88M Sell
53,761
-17,393
-24% -$647K 0.02% 660
2023
Q3
$3.12M Sell
71,154
-3,808
-5% -$186K 0.04% 421
2023
Q2
$3.7M Sell
74,962
-4,807
-6% -$222K 0.04% 408
2023
Q1
$3.31M Buy
+79,769
New +$3.31M 0.04% 391
2020
Q3
Sell
-7
Closed 548
2020
Q2
$0 Buy
7
+4
+133% +$174 ﹤0.01% 2181
2020
Q1
$0 Sell
3
-5
-63% -$180 ﹤0.01% 1899
2019
Q4
$0 Buy
+8
New +$228 ﹤0.01% 1804

Other funds holding ATRC

Orion Portfolio Solutions's ATRC Position: Q1 2025 in Review

Orion Portfolio Solutions increased its AtriCure (ATRC) stake by 43% in Q1 2025, buying an estimated $710K and bringing the position to 63,706 shares worth $2.06M. The position accounts for 0.02% of the portfolio, ranked #689.

Orion Portfolio Solutions first reported a position in ATRC in Q4 2019 and has held it in 12 quarters since. The position peaked at $3.7M in Q2 2023. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

  • Orion Portfolio Solutions held 63,706 shares of AtriCure worth $2.06M as of Q1 2025.
  • Orion Portfolio Solutions bought 19,122 AtriCure shares in Q1 2025, an estimated $710K.
  • AtriCure made up 0.02% of Orion Portfolio Solutions's portfolio in Q1 2025, its #689 holding.
  • Orion Portfolio Solutions first reported a position in AtriCure in Q4 2019 and has held it in 12 quarters since.
  • Orion Portfolio Solutions's AtriCure position peaked at $3.7M in Q2 2023.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.